Celularity Inc.
Celularity Inc. (CELU) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · CELU · as of Sep 30, 2025
Ownership Breakdown
41
Institutional Holders
▲ 6 vs Q2
$4.76M
Total Inst. Value
▲ $488,047 vs Q2
24.05M
Shares Outstanding
freeFloat 76.56%
2.30M
13F Shares Held
▲ 121,969 vs Q2
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
CELU largest shareholders · institutional ownership
Q3 2025 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
C V STARR & CO INC pharmaceutical preparations | 764.1K | 3.18% | 3.18% | $1.58B | Nov 12, 2025 | — held |
VANGUARD GROUP INC pharmaceutical preparations | 676.6K | 2.82% | 2.82% | $1.40B | Nov 7, 2025 | ▲ 176.5K |
GEODE CAPITAL MANAGEMENT, LLC pharmaceutical preparations | 139.3K | 58.00% | 58.00% | $288.44M | Nov 12, 2025 | ▲ 4.5K |
BLACKROCK, INC. pharmaceutical preparations | 103.8K | 43.23% | 43.23% | $214.93M | Nov 12, 2025 | ▲ 768 |
YORKVILLE ADVISORS GLOBAL, LP pharmaceutical preparations | 100.0K | 41.63% | 41.63% | $207.00M | Nov 18, 2025 | ▼ 100.0K |
STATE STREET CORP pharmaceutical preparations | 57.8K | 24.08% | 24.08% | $119.71M | Nov 14, 2025 | ▼ 7.6K |
VALMARK ADVISERS, INC. pharmaceutical preparations | 50.0K | 20.81% | 20.81% | $103.47M | Oct 24, 2025 | — held |
CITADEL ADVISORS LLC pharmaceutical preparations | 44.8K | 18.63% | 18.63% | $92.64M | Nov 14, 2025 | ▼ 15.0K |
RENAISSANCE TECHNOLOGIES LLC pharmaceutical preparations | 42.0K | 17.49% | 17.49% | $86.94M | Nov 13, 2025 | ▲ 29.8K |
HB WEALTH MANAGEMENT, LLC pharmaceutical preparations | 40.4K | 16.83% | 16.83% | $83.66M | Oct 23, 2025 | ▲ 40.4K |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q3 2025 vs prior quarter
Q3 2025
11
Increased
+302.7K shares8
New Positions
first time holders8
Decreased
−155.0K shares5
Sold Out
fully exitedNet shares change (top 50)
+147.6K
+302.7K / −155.0K
Net new holders
+6
8 new / 5 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
CELU insider trading · insider activity
Source: SEC Form 4
3
Buy transactions
6
Sell transactions
0.50
Buy/Sell ratio
$0M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
Brigido Stephen Pres., Functional Regeneration | Apr 13, 2026 | Tax Withhold | 268 | $1.28 | $343.04 | 9.5K | Form 4 ↗ |
Haines John R Senior Exec Vice President | Apr 13, 2026 | Tax Withhold | 583 | $1.28 | $746.24 | 30.2K | Form 4 ↗ |
Hariri Robert J Chief Executive Officer | Apr 13, 2026 | Tax Withhold | 1,182 | $1.28 | $1.5K | 2.85M | Form 4 ↗ |
Ling Geoffrey M.D. director | Jan 12, 2026 | Award | 19,231 | — | — | 256.0K | Form 4 ↗ |
LeVien Vincent director | Jan 12, 2026 | Award | 28,847 | — | — | 153.8K | Form 4 ↗ |
Diamandis Peter director | Jan 12, 2026 | Award | 20,385 | — | — | 394.1K | Form 4 ↗ |
Parks Diane L. director | Jan 12, 2026 | Award | 30,000 | — | — | 520.0K | Form 4 ↗ |
LeVien Vincent director | Dec 29, 2025 | Award | 156,250 | $1.20 | $187.5K | 156.3K | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Celularity Inc. (CELU) is primarily owned by institutional investors, who hold approximately 9.6% of total shares outstanding. Company insiders own approximately 23.44%, while retail and public investors account for the remaining 67.00%.
The largest institutional shareholder of Celularity Inc. is C V STARR & CO INC, holding approximately 764,069 shares — equal to 3.18% of outstanding shares — as of September 30, 2025.
A total of 41 institutional investors currently hold CELU stock, with a combined institutional value of approximately $4,755,556 as of the most recent 13F filing period.
Frequently asked questions
CELU ownershipCelularity Inc. (CELU) is primarily owned by institutional investors, who hold approximately 9.6% of shares. The largest shareholder is C V STARR & CO INC with a 3.18% stake. Company insiders hold 23.44%. Data sourced from SEC Form 13F as of September 30, 2025.